vimarsana.com
Home
Live Updates
Eiger BioPharmaceuticals, Inc. (EIGR) CEO David Cory on Q2 2
Eiger BioPharmaceuticals, Inc. (EIGR) CEO David Cory on Q2 2
Eiger BioPharmaceuticals, Inc. (EIGR) CEO David Cory on Q2 2022 Results - Earnings Call Transcript
Eiger BioPharmaceuticals, Inc. (NASDAQ:NASDAQ:EIGR) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Sarah Mathieson - SVP, Corporate Affairs David Cory -...
Related Keywords
Japan ,
Italy ,
Milan ,
Lombardia ,
Washington ,
United States ,
London ,
City Of ,
United Kingdom ,
Sriram Ryali ,
Michael Higgins ,
David Cory ,
Sarah Mathieson ,
Brian Skorney ,
Colin Hislop ,
Ingrid Choong ,
Robert Hazlett ,
Jeffrey Glenn ,
Eldon Mayer ,
Maurice Raycroft ,
Yigal Nochomovitz ,
Colleen Craig ,
Company Participants ,
Development Operations ,
Ladenburg Thalmann ,
European Commission ,
Corporate Affairs At Eiger ,
Nasdaq ,
International Liver Conference ,
Eiger Biopharmaceuticals Inc ,
Corporate Affairs ,
Clinical Development ,
Eiger Biopharmaceuticals ,
Conference Call August ,
Senior Vice President ,
Sri Ryali ,
Chief Financial Officer ,
Chief Commercial Officer ,
Vice President ,
Metabolic Diseases ,
Delta Cure Conference ,
Liver Conference ,
Innovatus Capital ,
Grand Rounds ,